Naya Biosciences Inc.
13F holders, Q3 2024 (September 30)12holders
3new positions
4sold out
1famous investor
$0.71avg. 13F price*
At the end of Q3 2024, 12 institutions reported holding Naya Biosciences Inc. in their 13F filings, unchanged from Q2 2024. 3 opened new positions and 4 sold out. The largest holders were CWC Advisors, LLC. ($71K), Vanguard Group Inc. ($38K) and Citadel Advisors ($37K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Naya Biosciences Inc.
- Filed as
- INVO BIOSCIENCE INC (Q3 2024)
- CUSIP
- 44984F401
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $46K |
| Exits | 4 | $11K |
All 13F filers, Q2 2024 → Q3 2024: 66,810 shares bought and 14,508 shares sold, net +52,302 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| CWC Advisors, LLC. | 0.07% | — | 100,477 | $71K |
| Vanguard Group Inc. | 0.00% | No change | 54,058 | $38K |
| Citadel Advisors | 0.00% | New | 52,621 | $37K |
| Geode Capital Management, LLC | 0.00% | Add +7.9% | 35,203 | $25K |
| Two Sigma Securities, LLC | 0.00% | Reduce -9.3% | 14,490 | $10K |
| UBS Group AG | 0.00% | New | 11,347 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -0.2% | 5,098 | $4K |
| Wells Fargo & Company | 0.00% | New | 250 | $178 |
| Osaic Holdings, Inc. | 0.00% | No change | 250 | $177 |
| Morgan Stanley | 0.00% | No change | 37 | $26 |
| Bank of America Corp. | 0.00% | Add +10.7% | 31 | $22 |
| Gleason Group, Inc. | 0.00% | No change | 3 | $2 |
"% of holder's portfolio" is NAYA BIOSCIENCES INC's weight in each manager's 13F, not the share of Naya Biosciences Inc. the manager owns.